TY - JOUR
T1 - Scleromyxedema, a positive effect with thalidomide
AU - Jacob, Sharon E.
AU - Fien, Sari
AU - Kerdel, Francisco A.
N1 - Scleromyxedema, a positive effect with thalidomide Jacob, S.E.; Fien, S.; Kerdel, F.A. Dermatology 213(2): 150-152 Scleromyxedema is a rare dermatological disorder marked by widespread symmetric 2- to 3-mm, firm, waxy, closely spaced papules involving the hands, forearms, face, neck, upper trunk and thighs. The most common extracutaneous manifestation of scleromyxedema is a benign plasma cell dyscrasia.
PY - 2006/8
Y1 - 2006/8
N2 - Scleromyxedema is a rare dermatological disorder marked by widespread symmetric 2- to 3-mm, firm, waxy, closely spaced papules involving the hands, forearms, face, neck, upper trunk and thighs. The most common extracutaneous manifestation of scleromyxedema is a benign plasma cell dyscrasia. Treatment of scleromyxedema is limited by the lack of long-term results, toxicity and significant adverse side effects. We report a severe case of scleromyxedema who had marked improvement when treated with thalidomide.
AB - Scleromyxedema is a rare dermatological disorder marked by widespread symmetric 2- to 3-mm, firm, waxy, closely spaced papules involving the hands, forearms, face, neck, upper trunk and thighs. The most common extracutaneous manifestation of scleromyxedema is a benign plasma cell dyscrasia. Treatment of scleromyxedema is limited by the lack of long-term results, toxicity and significant adverse side effects. We report a severe case of scleromyxedema who had marked improvement when treated with thalidomide.
KW - Immunosuppressives
KW - Scleromyxedema
KW - Thalidomide
UR - http://www.scopus.com/inward/record.url?scp=33747030601&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33747030601&partnerID=8YFLogxK
U2 - 10.1159/000093856
DO - 10.1159/000093856
M3 - Article
C2 - 16902294
SN - 1018-8665
VL - 213
SP - 150
EP - 152
JO - Dermatology
JF - Dermatology
IS - 2
ER -